doxorubicin-resistant ( l1210dox ) and daunorubicin-resistant l1210 ascites tumor cells ( l1210dnr ) ( multidrug-resistant tumor cells ) were therefore compared with cytosine-arabino-side-resistant ( l1210arac ) and cyclophosphamide-resistant l1210 ascites tumor cells ( l1210ctx ) ( not multi-drug-resistant tumor cells ) .
C0013089
doxorubicin
C0011015
daunorubicin